CD8A and cancer: Recent studies revealed that TAPBP is a major target for cancer immune evasion mechanisms and decreased TAPBP expression in cancer was associated with reduced CD8+ T cell-mediated killing of the tumor cells, lowered immune responses, and enhanced tumor metastases via downregulation of antigen presentation the MHC class I pathway [60, 61].